Table 4.
Author | Population | Size | Intervention | Results |
---|---|---|---|---|
Edward et al. 94 | Delirious patients after hip fracture | 16 | Donepezil vs placebo | No differences regarding presence (odd ratio = 0.9) and severity (effect size = −0.2 on 30-point MDAS) over time. |
Tagarakis et al. 95 | Delirious patients after cardiac surgery | 80 | Ondasetron vs haloperidol | Effective with no differences between ondasetron (61%) and haloperidol (58%) |
Tahir et al.96 | General patients with diagnosed delirium | 42 | Quetiapine vs placebo | Quetiapine improved 83% (p = .026) faster than placebo by DRS-R-98 severity |
van Eijk et al. 97 | Delirious patients diagnosed in intensive care unit | 104 | Haloperidol rivastigmine | Rivastigmine increased mortality (22% vs 5%, p = 0.07) with no decrease duration of delirium |
Devlin et al.98 | Delirious patients diagnosed in | 36 | Quetiapine vs placebo | Quetiapine added to as-needed haloperidol results in faster resolution (1 vs 4.5 days, p = 0.001) |
Kim et al.84 | Delirious patients with mostly malignancy | 32 | Risperidone vs olanzapine | Equally effective (65% vs 73%) with no differences(p = 0.71) |
Overshott et al. 99 | Various patients with diagnosed delirium | 15 | Rivastigmine vs placebo | No difference in duration of delirium between two group(6.3 vs 9.9 days, p = 0.5) |
Hu et al.100 | Various patients with diagnosed delirium | 175 | Haloperidol vs olanzapine vs placebo | Effective rates of olanzapine, haloperidol and placebo were 82%, 88%, and 31% (p < 0.01 vs placebo), respectively |
Breitbart et al. 101 | Hospitalized AIDS patients with delirium | 30 | Haloperidol vs chlorpromazine vs lorazepam | DRS scores improved significantly in haloperidol and chlorpromazine (p < 0.001) but not in lorazepam |
Grover et al.102 | Various patients with delirium | 64 | Haloperidol vs olanzapine vs risperidone | Significant (p < 0.001) reduction in severity scores but no differences between agents |
Han et al.103 | Various patients with delirium | 28 | Haloperidol vs risperidone | No significant difference in the mean MDAS scores between the two groups (p = 0.51) |
DRS, Delirium Rating Scale; DRS R-98, Delirium Rating Scale Revised; MDAS, Memorial Delirium Assessment Scale